Please provide your email address to receive an email when new articles are posted on . The FDA has announced the clearance of the first test to identify whether infections are methicillin-resistant ...

January 8, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a test for the rapid detection of methicillin-resistant Staphylococcus aureus, a test for the detection of ...

A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll 200 adults ...

Future Market Insights, in a recently published market report, offers an in-depth analysis of the current and future prospects of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment ...

Antibiotics are the old medicine cabinet standby for treating infections caused by multidrug-resistant Staphylococcus aureus, but as antimicrobial resistance continues to mount globally, scientists ...

Please provide your email address to receive an email when new articles are posted on . Researchers from the Georgia Institute of Technology and the CDC have developed a new laboratory test that can ...

Pneumonia caused by the bacterium Staphylococcus aureus is one of the most dangerous infections that can occur in hospital. Particularly worrying are multi-resistant strains, against which many ...

Clearance for these sample types will double the accessible market for KeyPath™ to more than 90% of U.S. hospitals. On May 6, 2011, MicroPhage received initial 510(k) clearance from the U.S. Food and ...